Troy A. Ignelzi - May 10, 2021 Form 4 Insider Report for Karuna Therapeutics, Inc. (KRTX)

Role
Chief Financial Officer
Signature
/s/ Troy Ignelzi
Stock symbol
KRTX
Transactions as of
May 10, 2021
Transactions value $
-$728,250
Form type
4
Date filed
5/12/2021, 05:28 PM
Next filing
Jun 16, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KRTX Common Stock Options Exercise $64.4K +7K +53.85% $9.20* 20K May 10, 2021 Direct
transaction KRTX Common Stock Sale -$770K -7K -35% $110.07 13K May 10, 2021 Direct F1
transaction KRTX Common Stock Options Exercise $1.84K +200 +1.54% $9.20* 13.2K May 12, 2021 Direct
transaction KRTX Common Stock Sale -$24K -200 -1.52% $120.00 13K May 12, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KRTX Option (right to buy) Options Exercise $0 -7K -3.47% $0.00 195K May 10, 2021 Common Stock 7K $9.20 Direct
transaction KRTX Option (right to buy) Options Exercise $0 -200 -0.1% $0.00 195K May 12, 2021 Common Stock 200 $9.20 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.